InvestorsHub Logo
Followers 1
Posts 133
Boards Moderated 0
Alias Born 03/30/2010

Re: None

Thursday, 12/29/2011 2:57:38 PM

Thursday, December 29, 2011 2:57:38 PM

Post# of 7234
Cell Therapeutics Inc. (CTIC US) rose 8.9 percent to $1.10 after gaining 16 percent earlier, the biggest intraday rise since Dec. 6. The Food and Drug Administration said the company’s pixantrone, which is under review for adults with non- Hodgkin’s lymphoma who received two or more prior lines of therapy, will be discussed by an advisory committee on Feb. 9.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.